Cancer
Conditions
Interventions
Sponsors
Osaka medical and pharmaceutical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Diagnosed with unresectable, recurrent, or metastatic cancer 2 Age 18 years or older at registration 3 Abdominal distension due to ascites 4 Expected survival of 3 weeks or longer 5 Most recent blood test within 14 days prior to registration shows the following values: a). Hemoglobin >= 6.0 g/dL b). Platelet count >= 50,000/mm3 c). Creatinine level < 2.0 mg/dL d). Total bilirubin level < 5.0 mg/dL 6 Written informed consent for study participation has been obtained from the subject.
Exclusion criteria
Exclusion criteria: 1 Received new chemotherapy (including molecularly targeted drugs) or immunotherapy within the past 3 weeks 2 Has active systemic or intraperitoneal infection 3 Has a systolic blood pressure below 100 mmHg 4 Has a psychiatric disorder or psychiatric symptoms that are judged to make participation in the study difficult 5 Other patients deemed unsuitable for inclusion by the principal investigator (or sub-investigator)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of severe hypotension | — |
Countries
Japan
Contacts
Public ContactToru Kadono
Osaka medical and pharmaceutical university hospital Cancer Chemotherapy Center
Outcome results
None listed